FP-ALDH2 activator 2 - Foresee Pharmaceuticals
Alternative Names: FP-ALDH2-activator-2 - Foresee PharmaceuticalsLatest Information Update: 31 Dec 2024
Price :
$50 *
At a glance
- Originator Foresee Pharmaceuticals
- Class Small molecules
- Mechanism of Action Aldehyde dehydrogenase 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurological disorders
Most Recent Events
- 20 Dec 2024 Foresee Pharmaceuticals has a composition of matter patent relating to ALDH2 activators for the treatment of neurological indication (Foresee Pharmaceuticals pipeline, December 2024)
- 20 Dec 2024 Preclinical trials in Neurological disorders in USA (PO) before December 2024 (Foresee Pharmaceuticals pipeline, December 2024)